Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Appointed CFO
Quarterly results
Consulting agrmnt
Director departure
Appointed director

NEPHROS INC (NEPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/01/2021 4/A Evans Daron (CEO Specialty Renal Products) has filed a Form 4 on NEPHROS INC
Txns: Paid exercise price by delivering 349 shares @ $2.7, valued at $942.3
05/02/2019 4/A Lask Alisa (Director) has filed a Form 4 on NEPHROS INC
Txns: Granted 86,546 options to buy @ $0.58, valued at $50.2k
12/20/2018 4/A Pinto Moshe (Director) has filed a Form 4 on NEPHROS INC
Txns: Granted 47,673 shares @ $0
02/27/2018 4/A Pinto Moshe (Director) has filed a Form 4 on NEPHROS INC
Txns: Granted 73,864 shares @ $0
Granted 40,284 options to buy @ $0.4999, valued at $20.1k
05/15/2017 4/A Astor Andrew (CFO) has filed a Form 4 on NEPHROS INC
Txns: Granted 209,355 options to buy @ $0.293, valued at $61.3k
06/05/2013 4/A Lambda Investors LLC (10% Owner) has filed a Form 4 on NEPHROS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy